Showing 1 - 10 of 1,269
This paper attempts to elucidate upon the current changes in the Indian Pharmaceutical Industry (IPI) brought about by the product patent regime 2005. The study relates the concept of strategic leadership as a source of competitive advantage for the firm in an industry where science and...
Persistent link: https://www.econbiz.de/10014041133
This study of the Indian Pharmaceutical Industry (IPI) attempts to identify existing and proposed business models for the choice of strategic options for the success of the Indian pharmaceutical industry in the New Patent Regime. As part of the study, a number of company and industry reports,...
Persistent link: https://www.econbiz.de/10013066289
In any assessment of the R&D capabilities of Indian companies, their patent holdings would have to be examined. Here we identify the number of patents assigned by four foreign governments to Indian pharmaceutical and biotechnological companies up to December 31, 2009. It is known that the United...
Persistent link: https://www.econbiz.de/10014130598
Patents are important for biotechnology and pharmaceutical companies. In order to remain valid, an issued patent has to be ‘maintained’ by the payment of fees to the patent office at three well-defined times over several years. The article examines whether Indian companies in these sectors...
Persistent link: https://www.econbiz.de/10014130632
Mergers and acquisitions (hereafter M&As) is a strategy used by firms for growth and expansion of their business in terms of products/services, scale of operations and the geographic coverage. In order to successfully overcome the challenges posed by globalization the corporate sector all over...
Persistent link: https://www.econbiz.de/10012956412
Persistent link: https://www.econbiz.de/10012815671
The present framework has incorporated the TRIPs agreement whose major provisions are based so as to protect the interest of western countries as well as to protect their industrial as well as economic interest in the developing and least developed countries. This paper is an attempt to analyze...
Persistent link: https://www.econbiz.de/10014185905
The TRIPS agreement has been one of the most contentious agreements of WTO. The pharmaceutical industry has been central to this debate, especially the case of India, which did not recognize product patents in pharmaceuticals before TRIPS and evolved as a major pharmaceuticals manufacturer and...
Persistent link: https://www.econbiz.de/10013250979
Persistent link: https://www.econbiz.de/10014340172
Persistent link: https://www.econbiz.de/10009231633